Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / COVID-19 - Page 78

COVID-19

Abbott provided update on ID NOW
Biotechnology | COVID-19

Abbott provided update on ID NOW

On May 14, 2020, Abbott’s ID NOW announced that was further clarifying product information to provide better guidance…

Read More Abbott provided update on ID NOWContinue

NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics

NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…

Read More NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19Continue

The  FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test
COVID-19 | FDA | Life Science History

The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care test

On May 14, 2020, the FDA alerted the public to early data that suggest potential inaccurate results from…

Read More The FDA informed public about possible accuracy concerns with Abbott ID NOW point-of-care testContinue

CureVac’s Optimized mRNA platform provides positive pre-clinical results at low dose for Coronavirus vaccine candidate
Biotechnology | COVID-19 | Vaccine

CureVac’s Optimized mRNA platform provides positive pre-clinical results at low dose for Coronavirus vaccine candidate

On May 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…

Read More CureVac’s Optimized mRNA platform provides positive pre-clinical results at low dose for Coronavirus vaccine candidateContinue

Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
COVID-19 | Life Science History

Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial

On May 14, 2020 Abivax announced it had received clearance from Franceメs National Agency for the Safety of…

Read More Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trialContinue

Vyriad announced development of new antibody test to determine protective immunity from COVID-19
COVID-19 | Life Science History

Vyriad announced development of new antibody test to determine protective immunity from COVID-19

On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…

Read More Vyriad announced development of new antibody test to determine protective immunity from COVID-19Continue

Countries begin large-scale screening for SARS-CoV-2 in sewage
Biotechnology | COVID-19 | Diagnostics

Countries begin large-scale screening for SARS-CoV-2 in sewage

On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…

Read More Countries begin large-scale screening for SARS-CoV-2 in sewageContinue

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
COVID-19 | Life Science History | Vaccine

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development

On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…

Read More First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine developmentContinue

ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2

On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…

Read More ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2Continue

AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
COVID-19 | FDA | Life Science History

AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer

On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…

Read More AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancerContinue

ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Biotechnology | COVID-19

ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…

Read More ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium modelContinue

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
Biotechnology | COVID-19 | Genomics | Non-Profit Research | Vaccine

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19

On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…

Read More University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19Continue

Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complications
COVID-19 | FDA | Life Science History

Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complications

On May 13, 2020, Royal Philips announced that it had received 510(k) clearance from the FDA to market…

Read More Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complicationsContinue

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
Biotechnology | COVID-19 | Diagnostics | FDA | Non-Profit Research

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test

On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…

Read More Thermo Fisher Scientific response to COVID-19 expanded to include new serology testContinue

University of Nebraska developed a COVID-19 screening mobile app
COVID-19 | Life Science History

University of Nebraska developed a COVID-19 screening mobile app

On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…

Read More University of Nebraska developed a COVID-19 screening mobile appContinue

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
COVID-19 | Life Science History

Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program

On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…

Read More Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead programContinue

Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
COVID-19 | Life Science History

Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients

On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…

Read More Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patientsContinue

Study confirmed cats can become infected with and may transmit COVID-19 to other cats
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Veterinary

Study confirmed cats can become infected with and may transmit COVID-19 to other cats

On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…

Read More Study confirmed cats can become infected with and may transmit COVID-19 to other catsContinue

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…

Read More National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19Continue

Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル System
COVID-19 | FDA | Life Science History

Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル System

On May 12, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s molecular…

Read More Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mル SystemContinue

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics | Vaccine

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…

Read More National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19Continue

U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts
COVID-19

U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts

On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…

Read More U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 effortsContinue

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut

On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…

Read More The Jackson Laboratory provided widescale COVID-19 testing in ConnecticutContinue

FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
COVID-19 | FDA | Life Science History

FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests

On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…

Read More FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic testsContinue

Combing through old drugs to find new ones for COVID-19
COVID-19 | Life Science History

Combing through old drugs to find new ones for COVID-19

On May 12, 2020, the Broad Instituteメs Drug Repurposing Hub announced that it had opened its repository of…

Read More Combing through old drugs to find new ones for COVID-19Continue

LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
CDC | COVID-19 | Life Science History

LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit

On May 12, 2020, LabCorpᆴ announced that its COVID-19 at-home collection test kit is now being offered to…

Read More LabCorp significantly expanded availability of Its COVID-19 at-home collection test kitContinue

Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19
COVID-19 | Life Science History

Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19

On May 12, 2020, Mylan announced, as part of its ongoing efforts to support patients and public health…

Read More Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19Continue

The  FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19
COVID-19 | FDA | Life Science History

The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19

On May 11, 2020, the FDA announced actions to accelerate the development of prevention and treatment options for…

Read More The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19Continue

NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
COVID-19 | Life Science History | Vaccine

NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key

On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…

Read More NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is keyContinue

Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality

On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…

Read More Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortalityContinue

Page navigation

Previous PagePrevious 1 … 76 77 78 79 80 … 98 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search